RxDoctor Payments Data

Athos Bousvaros

Pediatric Gastroenterology · Boston, MANPI 1528174885

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,800 of the $1,869 with a category attached, or 96.3%. Eli Lilly accounts for 96.3% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $1,800 and has fallen 96.5% since, to $63 in 2024.

$1,869in general payments, 2019–2025

Across 6 payments — averaging $311.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2K
  • Bristol Myers Squibb$63
  • Travere Therapeutics, Inc.$6
$647,889in research payments, 2019–2025

Across 45 payments — averaging $14,398 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$388K
  • Bristol Myers Squibb$98K
  • AbbVie$78K
  • Pfizer$66K
  • Janssen Research & Development, LLC$18K

What the payments were for

  • Consulting fees$1,80096%
  • Food & beverage$633%
  • Education$60%

General payments by program year

19
20
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,869 in reported general payments places this provider in the 70th percentile of 71 pediatric gastroenterology providers in Massachusetts.

See all pediatric gastroenterology providers in Massachusetts →

Most prescribed under Part D

DrugClaimsCost to plans & patients
WaterWater For Irrigation,sterile11$678

Paid to pharmacies, not to this prescriber.

Other pediatric gastroenterology in Boston

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →